Images List Premium Download Classic

Allergy

Allergy-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Allergy service management portal
Allergy Solutions, Inc.
June 22, 2017 - N°20170177802

Aspects of the present disclosure involve systems, programs, and methods for an allergy management system (ams). In general, the ams provides a system through which a practitioner or other user may manage allergy-related care for one or more patients. In one embodiment, the ams includes an application executed on a computing device, such as a tablet or other type of ...
NEW Compositions and methods relating to the treatment of diseases
Alfacyte Ltd
June 22, 2017 - N°20170174735

The present invention relates to compositions and methods for promoting the induction of a cell-mediated immune response (such as that mediated by th1 cells) and the suppression of a humoral or allergic immune response (such as that mediated by th2 and th17 cells). In particular, the invention relates to compositions and methods for preventing or treating allergy, such as food ...
Compositions and methods for modulation of rorgammat functions
Alfacyte Ltd
June 08, 2017 - N°20170159057

The present invention relates to expression of rorγt in cells and tissues and the effect of expression of this gene on proliferation of specific immune cells and in promotion of immune cell aggregates and in induction of il17 producing cells. Furthermore, the invention relates to methods and agents that may decrease function of the gene product (the ...
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Synergistic nutritional compositions and uses thereof
Mead Johnson Nutrition Company
June 08, 2017 - N°20170157242

Provided are nutritional compositions comprising a combination of a probiotic, dietary butyrate and/or a component for stimulating butyrate production in the human gut. Further disclosed are methods of accelerating tolerance to cow's milk allergy in a pediatric subject by providing said nutritional compositions to a target subject.
Peptide for vaccine
Circassia Limited
June 08, 2017 - N°20170157226

The present invention relates to compositions comprising peptides for preventing or treating allergy to house dust mites, and in particular to optimal combinations of peptides for preventing or treating said allergy.
Mobile chamber apparatuses and related methods
Inflamax Research Inc.
June 08, 2017 - N°20170156961

A mobile chamber apparatus includes a support structure of inflatable support members, and a chamber assembly. The inflatable support members may include transverse and upright sections. The chamber assembly may include a top wall, a bottom wall, and one or more side walls. Connectors may detachably couple the support structure and the chamber assembly. Installed, the support structure supports the ...
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Human fgfr2b extracellular domain and nucleic acid for coding same
Guangzhou Shenglu Biotech Limited Company
June 01, 2017 - N°20170152299

Provided are wild-type, s252w mutant-type, and p253r mutant-type fgfr2b extracellular segments and truncated proteins thereof, coding genes of the foregoing proteins, a recombinant vector comprising the genes, a host cell, a method for preparing the proteins, and a fusion protein of the proteins and an fc segment. Also provided are applications of the proteins and a composition ...
Compound of glycosaminoglycan and its fabrication method as well as application
Holy Stone Healthcare Co., Ltd.
June 01, 2017 - N°20170151336

The present invention is related to a compound conjugating a drug with a glycosaminoglycan, such as hyaluronic acid (ha), where the drug is useful for the treatment of diseases such as inflammation, auto-immune disease, allergy, infection and preferably cancer. The conjugated compound of the present invention can increase the concentration of drug at the specific site of disease by an ...
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
Holy Stone Healthcare Co., Ltd.
May 25, 2017 - N°20170145417

The invention provides novel immune regulatory oligonucleotides (iro) as antagonist of tlrs and methods of use thereof. These iros have unique sequences that inhibit or suppress tlr-mediated signaling in response to a tlr ligand or tlr agonist. The methods may have use in the prevention and treatment of cancer, an autoimmune disorder, airway inflammation, inflammatory disorders, infectious disease, skin disorders, ...
Allergy warning and protection system and method
Holy Stone Healthcare Co., Ltd.
May 04, 2017 - N°20170124839

An allergy warning and protection system and method to proactively warn a user and protect a dependent individual, such as a child, suffering from allergies. The system comprises a beacon housed within a wearable, such as a bracelet, that is worn by the dependent. The beacon has an associated identifier that is linked to data stored on a server that ...
Humanized anti-ige antibodies that crosslink cd23 on b lymphocytes but do not sensitize mast cells
Academia Sinica
May 04, 2017 - N°20170121425

A novel humanized anti-ige antibody is disclosed. The antibody is capable of binding to free ige, membrane-bound ige on b lymphocytes, ige bound by cd23, but not to ige bound by high-affinity ige. Fc receptor on mast cells. The present invention relates to the treatment of ige-mediated diseases, including allergic asthma, allergic rhinitis, atopic dermatitis, food allergy, chronic spontaneous (idiopathic) ...
Anti-human chemokine (c-c motif) receptor 4 immunotoxins
The General Hospital Corporation
May 04, 2017 - N°20170121419

Anti-human chemokine (c—c motif) receptor 4 immunotoxins and methods of use thereof, e. G., for depleting tregs as an immunotherapy for the treatment of cancer; for the treatment of cancers associated with ccr4+ tumor cells such as skin homing cutaneous t cell lymphoma, adult t cell leukemia/lymphoma, and acute t-cell lymphoblastic leukemia; and for the depletion of cccr4+ ...
Benzimidazole derivatives as pi3 kinase inhibitors
Glaxosmithkline Llc
April 27, 2017 - N°20170112844

This invention relates to the use of benzimidazole derivatives for the modulation, notably the inhibition of the activity or function of the phosphoinositide 3′ oh kinase family (hereinafter pi3 kinases), suitably, pi3kα, pi3kδ, pi3kβ, and/or pi3kγ. Suitably, the present invention relates to the use of benzimidazoles in ...
Allergy Patent Pack
Download + patent application PDFs
Allergy Patent Applications
Download + Allergy-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Allergy-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method of genetically altering and producing allergy free cats
Fujitsu Limited
April 20, 2017 - N°20170107540

A transgenic cat with a phenotype characterized by the substantial absence of the major cat allergen, fel d i. The phenotype is conferred in the transgenic cat by disrupting the coding sequence of the target gene with a specialized construct. The phenotype of the transgenic cat is transmissible to its offspring.
Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring
The Brigham And Women's Hospital, Inc.
April 20, 2017 - N°20170107300

Described herein are methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring based on the level of tigit, flg2 and/or il-33 expression and/or activity. In some embodiments, the methods and compositions described herein are directed to treatment and/or therapy monitoring of cancer and/or infections (e. G., chronic viral infection, intracellular and/...
Met e 1 tropomyosin variants for use in allergen-specific immunotherapy
The Regents Of The University Of California
April 20, 2017 - N°20170107265

The present invention provides isolated met e 1 polypeptides and nucleic acids encoding the isolated polypeptides that can prevent and/or alleviate an allergic response to shellfish tropomyosin. The polypeptides are based on the shrimp tropomyosin met e 1 protein and have been modified to act as hypoallergens. The met e 1 hypoallergens have low to no ige reactivity or allergenicity and are ...
Device with integrated allergy testing
Teleflex Medical Incorporated
April 13, 2017 - N°20170100070

A coupler for indicating the presence of a substance in blood is disclosed. The coupler includes a housing and a test strip. The housing has a proximal end and a distal end, and defines a hollow interior for receiving withdrawn blood. The test strip is held within the hollow interior of the housing. The housing removably couples with a medical ...
Dna aptamers specific to cd200r1 and their therapeutic uses
D5pharma Inc.
April 06, 2017 - N°20170096670

Disclosed are short dna aptamers that selectively recognize cd200r1, a protein expressed on the surface of myeloid and lymphoid cells that delivers immune inhibitory signals to modulate inflammation when engaged with its ligand, cd200. Also disclosed is the use of said aptamers as therapeutic agents, for the purpose of decreasing inflammatory response; treatment of spinal cord injury; treatment of ...
Inhibition of gliadin peptides
Alba Therapeutics Corporation
April 06, 2017 - N°20170096451

Novel compounds and methods for the inhibition of biological barrier permeability and for the inhibition of peptide translocation across biological barriers are identified. Assays for determining modulators of biological barrier permeability and for peptide translocation across biological barriers are provided. Methods for treating diseases relating to aberrant biological barrier permeability and peptide translocation across biological barriers are provided. Such diseases ...
Methods and compositions for treating allergy and inflammatory diseases
Baylor Research Institute
April 06, 2017 - N°20170095573

Described herein are therapeutic approaches with immune modifiers of the th2 pathway for the treatment of allergic and inflammatory diseases. Aspects of the disclosure relate to methods for decreasing th2-type cell responses in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an anti-dectin-1 antibody or antigen binding fragment thereof operatively linked to ...
Allergen for prophylactic treatment of allergy
Alk-abellÓ A/s
March 30, 2017 - N°20170087231

A composition comprising at least one first allergen, which is a respiratory allergen belonging to a first biological source material group, for use in prophylactic treatment of allergy to at least one second allergen, which is selected from the group consisting of a respiratory and a venomous allergen belonging to a second biological source material group and a food allergen ...
Loading